封面
市場調查報告書
商品編碼
1461335

CRISPR 技術市場:按產品、按應用、按最終用戶、按地區 - 市場規模、佔有率、展望、機會分析,2024-2031 年

CRISPR Technology Market, By Product, By Application, By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

出版日期: | 出版商: Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年,全球 CRISPR 技術市場將達到 36.421 億美元,預計在預測期內(2024-2031 年)年複合成長率為 19.2%。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 36.421 億美元
實際資料 2019-2023 預測期 2024-2031
預測期2023/2024-2030/2031年複合成長率 19.20% 2030/2031 年預測值 124.61億美元
2024 年按地區分類的 CRISPR 技術全球市場規模(百萬美元)
CRISPR技術市場-IMG1

CRISPR 技術正在推動醫學、製藥、生物技術和農業領域基因組編輯的進步,使世界各地的科學家能夠透過更快、更有效率的基因組編輯來研究這些領域。 CRISPR 也被用於糾正遺傳缺陷、治療人類疾病和收穫更好的作物品種。 CRISPR 有許多潛在的應用,包括治療和預防疾病傳播、糾正遺傳缺陷和改良作物。 CRISPR-Cas9系統有廣泛的應用。在醫學領域,它應用於癌症、病毒感染、遺傳疾病和病原體檢測的研究。 CRISPR是一種有潛力改變世界的基因編輯技術。

市場動態:

COVID-19在全球範圍內的爆發、正在進行的臨床試驗數量的增加以及基因編輯工具的不斷探索是預計在預測期內促進全球CRISPR技術市場成長的關鍵因素。例如,2020 年 3 月,多倫多大學的科學家開發了 CHyMErA,這是一種基於 CRISPR 的工具,用於更通用的基因組編輯。

CRISPR技術在COVID-19的預防和控制方面具有巨大的應用潛力。 2020 年 3 月,紐約基因組中心的研究人員開發了一種新的 CRISPR篩檢技術,該技術針對 RNA,包括新型病毒 (COVID-19) 的 RNA。此外,2019 年 11 月,瑞士蘇黎世聯邦理工學院的研究人員以 CAS12a 取代了 CAS9 酶,使他們能夠編輯 25 個目標位點的基因。

本研究的主要特點

  • 本報告對全球CRISPR技術市場進行了詳細分析,並提出了以2023年為基準年的預測期(2024-2031)的市場規模和年複合成長率(CAGR%)。
  • 它還闡明了各個細分市場的潛在商機,並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 它根據以下參數(例如公司亮點、產品系列、主要亮點、財務表現和策略)介紹了全球 CRISPR 技術市場的主要企業。
  • 該報告的見解預計將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球 CRISPR 技術市場報告迎合了該行業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過分析全球 CRISPR 技術市場時所使用的各種策略矩陣來促進決策。

目錄:

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會地圖 (COM)

第3章市場動態、法規及趨勢分析

  • 市場動態
    • CRISPR 的需求和採用增加
    • CRISPR高成本
    • COVID-19 爆發(全球大流行)
  • 影響分析
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

第4章全球 CRISPR 技術市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • COVID-19 流行病學
  • 供需面分析
  • 經濟影響

第 5 章全球CRISPR 技術市場(按產品),2019-2031 年

  • 介紹
  • 酵素
  • 套件和試劑
  • 引導RNA
  • 其他

第6章 2019-2031 年全球 CRISPR 技術市場(按應用)

  • 介紹
    • 2024年及2031年市場佔有率分析(%)
    • 與前一年同期比較成長分析
    • 細分市場趨勢
  • 生物醫學
    • 介紹
    • 市場規模及預測、與前一年同期比較成長率
  • 農業
    • 介紹
    • 市場規模及預測、與前一年同期比較成長率
  • 產業
    • 介紹
    • 市場規模及預測、與前一年同期比較成長率
  • 其他
    • 介紹
    • 市場規模及預測、與前一年同期比較成長率

第 7 章 2019-2031 年全球 CRISPR 技術市場(按最終用戶)

  • 介紹
  • 製藥和生物技術公司
  • 學術和政府研究機構
  • 其他(CRO等)

第8章2019-2031年全球CRISPR技術市場(按地區)

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
  • 其他

第9章 競爭格局

  • Merck KGaA
  • Thermo Fisher Scientific
  • Origene Technologies, Inc.
  • New England Biolabs
  • GenScript
  • GeneCopoeia, Inc.
  • Cellecta, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.(Horizon Discovery Ltd.)
  • Danaher Corporation(Integrated DNA Technologies)

第10章分析師建議

  • 繁榮與衰落
  • 綜合機會圖

第11章 章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI5175

The global CRISPR technology market is estimated to be valued at US$ 3,642.1 Mn in 2024 and is expected to exhibit a CAGR of 19.2% during the forecast period (2024-2031).

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 3,642.1 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 19.20% 2030/2031 Value Projection: US$ 12,461 Mn
Global CRISPR Technology Market Value (USD MN), by Region, 2024
CRISPR Technology Market - IMG1

CRISPR technology is driving advances in genome editing across medicine, pharmaceutical, biotechnology, and agriculture, which has enabled scientists to conduct research in these fields through faster and more efficient genome editing across the world. CRISPR is also used to correct genetic defects, treat human diseases, and yield better crop varieties. It has a number of potential applications that include treating and preventing the spread of diseases, correcting genetic defects, and also, improving crops. The CRISPR-Cas9 system has a wide diversity of applications. In medicine, it has been applied in research related to cancer, virus infections, genetic diseases and detection of pathogens. CRISPR is a technology that can be used to edit genes and, as such, will likely change the world.

Market Dynamics:

The outbreak of COVID-19 across the globe, increasing number of ongoing clinical trials, and expanding research in gene editing tools are some major factors expected to augment growth of the global CRISPR Technology market during the forecast period. For instance, in March 2020, scientists at the University of Toronto developed CHyMErA, a CRISPR-based tool for more versatile genome editing.

CRISPR technology have great potential for application in both the prevention and control of COVID-19. In March 2020, researchers at New York genome center developed a new CRISPR screening technology to target RNA, including RNA of novel viruses (COVID-19). Moreover, in November 2019, researchers at ETH Zurich, Switzerland, swapped CAS9 enzyme for CAS 12a, which allowed the researchers to edit genes in 25 target sites.

Key features of the study:

  • This report provides in-depth analysis of the global CRISPR Technology market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global CRISPR Technology market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific, Origene Technologies, Inc., New England Biolabs, GenScript, GeneCopoeia, Inc., Cellecta, Inc., Agilent Technologies, Inc., PerkinElmer, Inc. (Horizon Discovery Ltd.), and Danaher Corporation (Integrated DNA Technologies), among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global CRISPR Technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CRISPR Technology market.

Detailed Segmentation:

  • Global CRISPR Technology Market, By Product:
    • Enzymes
    • Kits & Reagents
    • Guide RNA
    • Others
  • Global CRISPR Technology Market, By Application:
    • Biomedical
    • Agricultural
    • Industrial
    • Others
  • Global CRISPR Technology Market, By End User:
    • Pharmaceutical companies and Biotechnology Companies
    • Academics and Government Research Institutes
    • Others (CROs etc.)
  • Global CRISPR Technology Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Key Players Insights
    • Merck KGaA
    • Thermo Fisher Scientific
    • Origene Technologies, Inc.
    • New England Biolabs
    • GenScript
    • GeneCopoeia, Inc.
    • Cellecta, Inc.
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc. (Horizon Discovery Ltd.)
    • Danaher Corporation (Integrated DNA Technologies)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising demand and adoption of CRISPR
    • High cost of CRISPR
    • The outbreak of COVID-19 (global pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global CRISPR Technology Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global CRISPR Technology Market, By Product, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Enzymes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Guide RNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global CRISPR Technology Market, Application, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Biomedical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Agricultural
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Industrial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global CRISPR Technology Market, By End User, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical companies and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Academics and Government Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others (CROs etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global CRISPR Technology Market, By Region, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)

9. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Origene Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GenScript
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GeneCopoeia, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cellecta, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer, Inc. (Horizon Discovery Ltd.)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation (Integrated DNA Technologies)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact